Carregant...
Unexpected responses to EGFR inhibition in NSCLC
The presence of activating mutations of the epidermal growth factor receptor (EGFR)-gene identifies a distinct and clinically relevant molecular subset of non-small-cell lung cancer. It is now well demonstrated that EGFR tyrosine kinase inhibitors (TKIs) gefitinib and erlotinib are superior to stand...
Guardat en:
| Publicat a: | Respir Med Case Rep |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4681892/ https://ncbi.nlm.nih.gov/pubmed/26744648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2015.06.006 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|